New, Late-onset Relapsing-remitting Multiple Sclerosis in a Woman in Her 60s After SARS-CoV-2 Vaccination
Overview
Overview
Journal
Clinics (Sao Paulo)
Publisher
Elsevier
Specialty
General Medicine
Date
2024 Dec 14
PMID
39674029
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Noe A, Dang T, Axelrad C, Burrell E, Germano S, Elia S
. BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists. Front Immunol. 2023; 14:1242380.
PMC: 10485613.
DOI: 10.3389/fimmu.2023.1242380.
View
2.
Finsterer J
. Neurological Adverse Reactions to SARS-CoV-2 Vaccines. Clin Psychopharmacol Neurosci. 2023; 21(2):222-239.
PMC: 10157009.
DOI: 10.9758/cpn.2023.21.2.222.
View
3.
Kyo C, Kobayashi T, Iwama S, Kosugi R, Sawabe F, Hayafusa R
. A case of hypophysitis after COVID-19 vaccination with a detection of anti-pituitary antibody, with review of literature. Endocr J. 2024; 71(8):799-807.
DOI: 10.1507/endocrj.EJ24-0061.
View
4.
Toljan K, Amin M, Kunchok A, Ontaneda D
. New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure. J Neuroimmunol. 2021; 362:577785.
PMC: 8656147.
DOI: 10.1016/j.jneuroim.2021.577785.
View
5.
Alluqmani M
. New Onset Multiple Sclerosis Post-COVID-19 Vaccination and Correlation With Possible Predictors in a Case-Control Study. Cureus. 2023; 15(3):e36323.
PMC: 10108897.
DOI: 10.7759/cureus.36323.
View